$B6Z<@45$N$$$m$$$m!!$=$N#7(B


$B-6(B.$B6Z86@-<@45!J(Bmyopathies$B!K(B


$B#1#3!%(B$B%_%H%3%s%I%j%"IB(B$B!J(Bmitochondrial diseases)
$B!!%_%H%3%s%I%j%"$O%(%M%k%.!<$r;:@8$9$k:YK&Fb>.4o41$G$9!#%_%H%3%s%I%j%"$O$h$/o$r$-$?$9$H!"BgNL$N%(%M%k%.!<$rI,MW$H$9$k9|3J6Z!"Cf?u?@7P7O$K$^$:0[>o$r$-$?$9$N$G$9!#%_%H%3%s%I%j%"IB$O$7$P$7$P%_%H%3%s%I%j%"G>6Z>I$H8F$P$l$k$N$O$=$N$?$a$G$9!#?46Z$bEvA3?/$5$l$k$7!"FqD0!"E|G"IB!"?U>c32$J$I$N9gJ;>I$bB?$/$_$i$l$^$9!#%_%H%3%s%I%j%"IB$N#6#0!<#7#0!s$O0J2<$K=R$Y$k$$$o$f$k#3BgIB7?$KB0$7$^$9!##3BgIB7?0J30$G$O(BLeigh$BG>>I!"%A%H%/%m!<%`#c;@2=9ZAG7gB;$,:G$bB?$/Js9p$5$l$F$$$^$9!##3BgIB7?$H(BLeigh$BG>>I$NNW>2E*$^$H$a$rI=#6$K<($7$^$7$?!#(B
$BIB!!7?(B $B#C#P#E#O(B
$B!JK}@-?J9T@-304c6ZKcac!K(B
$B#M#E#L#A#S(B
$B!J%a%i%9!K(B
$B#M#E#R#R#F(B
$B!J%^!<%U!K(B
$B#L#e#i#g#hG>>I(B
$B!J%j!>I!K(B
$B2HB2Nr!JJl7O0dEA!K(B $B!](B $B!\(B $B!\(B $B!\!J(B20%$B$N$_!K(B
$BH/>IG/Np(B $B>.;y!A(B70$B:P(B 2$B!A(B15$B:P(B $B>.;y!A(B40$B:P(B $BF};y(B
$BNW(B

$B>2(B

$B>I(B

$B>u(B
$BDc?HD9(B
$BCNG=Dc2<(B
$B6ZNODc2<(B
$B462;@-FqD0(B
$B<~4|@-F,DK!&SREG(B
$BHi $BJRKcac!&H>LU(B
$Ba[Z;(B
$B%_%*%/%m!<%L%9(B
$B>.G><:D4(B
$B304c6ZKcac(B
$BLVKl?'AGJQ@-(B
$B?4EAF3>c32(B
$B!\(B
$B!]!A!^(B
$B!\(B
$B!\(B
$B!](B
$B!](B
$B!](B
$B!](B
$B!](B
$B!](B
[$B!\(B]
[$B!\(B]
[$B!\(B]
$B!\(B
$B!\(B
$B!\(B
$B!\(B
[$B!\(B]
[$B!\(B]
[$B!\(B]
[$B!\(B]
$B!](B*
$B!](B
$B!](B
$B!](B
$B!](B
$B!\(B
$B!\(B
$B!\(B
$B!\(B
$B!](B
$B!](B
$B!](B
[$B!\(B]
[$B!\(B]
[$B!\(B]
$B!](B
$B!](B
$B!](B
$B!](B
$B!\(B
$B!\(B
$B!](B
$B!](B
$B!](B
$B!](B
$B!\(B
$B!\!A!](B
$B!](B
$B!](B
$B!](B
$B!](B
$B8!(B
$B::(B
$B=j(B
$B8+(B
$B9bF};@7l>I(B
$B?q1U%?%s%Q%/e>:(B
$B#C#T0[>o!'G>0`=L(B
$B6I=j@-Dc5[<}0h!$C8As5e@P3%2=(B
$B!\(B
$B!\(B
$B!](B
$B!](B
$B!\(B
$B!](B*
$B!\(B
$B!\(B
$B!\(B
$B!](B
$B!\(B
$B!](B
$B!\(B
$B!](B
$B!\(B
$BG>44!"G>4pDl3K$NJQ2=(B
$B6Z(B
$B@8(B
$B8!(B
$B#R#R#F(B
$B#S#S#V(B
$B!\(B
$B!](B*
$B!\(B
$B!\(B
$B!\(B
$B!\(B
$B!](B
$B!](B
$B;@AG7gB;!JJ#9gBN!K(B $B-8!d-5(B $B-5(B $B-8(B $B-8(B(10%$B$N$_(B)
mtDNA$B0[>o(B $B7g<:(B($B $BE@JQ0[(B(3243,3271) $BE@JQ0[(B(.8344) $BE@JQ0[(B(8933)**
CPEO:chronic progressive external ophthalmoplegia, MELAS:mitochondrial myopathy,encephalopathy,lactic acidosis,and stroke-like episodes, MERRF:myoclonus epilepsy associated with ragged-red fibers, RRF:ragged-red fibers, SSV:strongly SDH-reactive blood vessels, CT:computed tomography, mtDNA:mitochondrial DNA
*:$B$^$l$K!\(B,**$B!'45
$BI=#6(B:$B%_%H%3%s%I%j%"IB$N#3BgIB7?$H(BLeigh$BG>>I$NFCD'(B

$B!J#1!KIB0x!"IBBV!"IBM}(B
$B!!I=#6$K<($7$?$h$&$K#3BgIB7?$K$O$=$l$>$l<@45FC0[E*$J%_%H%3%s%I%j%"#D#N#A!J(BmtDNA$B!KJQ0[$r$_$^$9!#$^$?(BLeigh$BG>>I$NLs#2#0!<#3#0!s$b(BmtDNA$B$NJQ0[$K$h$k$3$H$,CN$i$l$F$$$^$9!#%A%H%/%m!<%`#c;@2=9ZAG7gB;$N0lIt$O3K0dEA;R$NJQ0[$K$h$k$3$H$,L@$i$+$K$5$l$F$$$^$9!#$=$l$O%A%H%/%m!<%`#c;@2=9ZAG$N9g@.$K4X78$9$k0dEA;R!"(BSURF1$B0dEA;R$NJQ0[$K$h$k$b$N$G$7$?!#$3$NIB5$$O3K0dEA;R$NJQ0[$G$9$+$i!">o@w?'BNNt@-0dEA$r$H$j$^$9!#(B
$B!!(BmtDNA$B$O4D>u$N#D#N#A$G!"#1#6!"#5#6#91v4pBP$+$i$J$C$F$$$F!"%$%s%H%m%s$O$J$/A4$F%(%/%=%s$+$i$J$C$F$$$^$9!J?^#3#0!K!#$o$l$o$l$NBN$N:YK&$N%_%H%3%s%I%j%"$OA4$FJl?FM3Mh$G$"$k$N$G(BmtDNA$BJQ0[$NI8u72$r=|$/!K$OJl7O0dEA$r<($7$^$9!#(B


$B?^#3#0(B:$B%_%H%3%s%I%j% $B ND:$BJ#9gBN-5(B

CO:$B%7%H%/%m%`#c%*%-%7%@!<%<(B($BJ#9gBN-8(B)

ATP:ATP$B9g@.9ZAG(B

cyt b:$B%7%H%/%m%`#b$N%3!<%INN0h(B

CPEO$B$NLp0u$O$3$NHO0OFb$G$$$m$$$m$JD9$5$N7g<:$r8+$k!#(B
$B30B&(B:$B=E:?(B, $BFbB&(B:$B7Z:?(B
$B?^#3#0(B:$B%_%H%3%s%I%j%"(BDNA(mtDNA)$B$H
$B!!(BMtDNA$BJQ0[$r$b$D<@45$G$O!"A4$F$N%_%H%3%s%I%j%"$,0[>o$G$O$/!"@5>o$J$b$N$b6&B8$7$^$9!J$=$l$O(Bheteroplasmy$B$H8F$P$l$F$$$^$9!K!#@5>o!'JQ0[#D#N#A$NHfN($O0lDj$G$O$J$/!"8DBN4V!"F1$88DBN$G$bAH?%4V$G0[$J$j$^$9!#JQ0[$7$?%_%H%3%s%I%j%"$,$h$jB?$/C_@Q$7$?AH?%$[$I!"$h$j6/$$>I>u$r<($9$H?dDj$5$l$F$$$^$9!#$?$H$($Pg9B!$K8B$C$F!"JQ0[(BmtDNA$B$,B?$/$"$l$Pg9B!$,?/$5$l!"E|G"IB$,A07J$KN)$A$^$9!#$3$N$h$&$K$"$kFCDj$NAH?%$,?/$5$l$k$3$H$rAH?%FC0[@-!J(Btissue specificity)$B$H$$$$$^$9!#(B
$B!!%_%H%3%s%I%j%"IB$NBgH>$O9|3J6Z$,?/$5$l$k$N$G!"9|3J6Z:YK&$N%_%H%3%s%I%j%"$K7ABV3XE*$J0[>o$r$_$^$9!#6Z@~0]Fb$N%_%H%3%s%I%j%"$O5pBg2=$7!"$=$N?t$bA}2C$7$^$9!#A}2C$7$?%_%H%3%s%I%j%"$O(BGomori$B%H%j%/%m!<%`JQK!$H$$$&@w?'$G@V@w$7!"$9$3$7%\%m%\%m$7$?46$8$rM?$($k$N$G!#@V?'$\$m@~0]!J(Bragged-red fiber: RRF)$B$H$h$P$l$F$$$^$9!J?^#3#1!K!#(B
$B?^#3#1(B:$B@V?'$\$m@~0](B $B@V?'$\$m@~0]!#(B

$B%4%b%j%H%j%/%m!<%`JQK!@w?'$H$$$&4JC1$J@w?'$G!"@5>o6Z!J:8(B:N$B!K$G$O@V$$pyN3>u$N%_%H%3%s%I%j%"$O$[$H$s$I8+$($J$$!#%_%H%3%s%I%j%"IB(B($B1&(B:Mit Dis)$B$G$O6Z@~0]$NBg>.ITF1$H@V$/@w$^$k6Z@~0]!J@V$$$N$OA4$F0[>o$KA}2C$7$?%_%H%3%s%I%j%"!K$,$_$i$l$k!#B?$/$N>l9g!"$3$N@V?'$\$m@~0]$,$"$k$H%_%H%3%s%I%j%"IB$H?GCG$G$-$k!#(B
$B?^#3#1(B:$B@V?'$\$m@~0](B

$BEE;R82Hy6@$G8+$k$H%_%H%3%s%I%j%"$O5pBg2=$7!"J#;($KA}?#$7$?%/%j%9%F!J(Bcristae)$B$r$b$A!"$7$P$7$PN`3J;RMMIuF~BN(B(paracrystalline inclusion)$B$r$b$C$F$$$^$9!#(B
$B!J#2!K>I>u(B
$B!y(B$BK}@-?J9T@-304c6ZKcac>I8u72(B$B!J(Bchronic progressive external ophthalmoplegia: CPEO)
$B!!K\<@45$NLs#7#0!<#8#0!s$N45(B(95%$B0J>e(B)$B$OFMA3JQ0[$K$h$k$b$N$G0dEA@-$O$"$j$^$;$s!#(B
$B!!H/>I$O>.;y4|$+$i@.?M$^$G$HI}9-$/!"#1#0!<#2#0:P$K5$IU$+$l$k$3$H$,:G$bB?$$$N$G$9!#$^$:4cb[2e$^$V$?$,$5$,$k$3$H!K$G5$IU$+$l$^$9!#IB=i4|$OJRJ}$N$_$N$3$H$b$"$j$^$9$,!"AaHUN>B&@-$N4cb[2I>u$N$_$N$b$N$b$$$^$9$,!"BgH>$O0WHhO+@-$H$+;M;h$N6ZNODc2<$bH<$$$^$9!#4c>I>u!"LVKl?'AGJQ@-!"?4EAF3>c32$rH<$&$b$N$O(BKearns-Sayre syndrome (KSS)$B$H$h$P$l$F$$$^$9!#(BKerns $B$H(BSayre$B$O$3$NIB5$$r$_$D$1$??M$NL>A0$G$9!#$3$NIB5$$G$OFqD0!"Dc?HD9!"?q1U$NCAGrA}2C$r$h$/G'$a$^$9!#$^$?MD>/;~$G$OCNE*B`9T$r$7$P$7$PH<$$$^$9!#(B
$B7l@6F};@CM$N>e>:!"6Z@88!$G@V?'$\$m@~0]!J(Bragged-red fiber$B!K$NB8:_$N3NG'!"%A%H%/%m!<%`#c;@2=9ZAG@w?'$G9ZAG3h@-$,7gB;$7$?@~0]$,$"$k$3$H!JItJ,7gB;!K$G!"?GCG$,3NDj$7$^$9!#9|3J6ZFb$N(BmtDNA$B$K$OJQ0[$,$_$i$l$^$9$,!"7l1U$+$iJ,N%$7$?$b$N$K$O$_$i$l$^$;$s!#$9$J$o$A!"K\>I$O7l1U$G$O0dEA;R?GCG$O=PMh$:!"6Z@88!$,I,MW$G$9!#(B
$B!!<#NEK!$K$OFCJL$J$b$N$O$"$j$^$;$s!#%3%(%s%6%$%`#Q@=:^!J%N%$%-%N%s!K$NB?$a$NEjM?$G8z2L$,$"$k?M$,$$$^$9!#L\$,2<$,$C$F$b$N$,8+$:$i$$J}$K$O!"Fs=Eb[$r:n$k%"%$%W%C%A$H$$$&$N$,2=>QIJ20$5$s$K$"$j$^$9!#$$$A$I;n$5$l$F$O$$$+$,$G$9$+!#(B

$B!y(B.$B%a%i%9(B$B!J(Bmitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episodes$B!'(BMELAS$B$O?@7P3XMQ8l=8$G$O!"!V%_%H%3%s%I%j%"G>6Z>I!&F};@%"%7%I!<%7%9!&G>B4CfMM>I8u72!W$HLu$5$l$F$$$^$9$,!"0lHL$K$O%a%i%9$H8F$P$l$F$$$^$9(B)
$B!!G>B4CfMM>I>u$rI>u$H$9$k<@45$G!"Jl7O0dEA!JJl$+$i;R$I$b$X$N0dEA!K$r$H$j$^$9!#(BmtDNA$B$NE>0\!J(Bt)$B#R#N#A(BLeu(UUR)$B$N%3!<%INN0h$K$"$k#3!"#2#4#3HVL\$N#A"*#GJQ0[!J#3#2#4#3JQ0[!K$r$H$k$b$N$,#8#0!s!"#3#2#7#1HVL\$N#T"*#CJQ0[$,#1#0!s$G$9!#(B
$B!!K\>I$OJl7O0dEA$r$H$k$N$G!"Jl?F!"F1K&$NB?$/$OJQ0[$r$b$C$F$$$^$9!#$7$+$7JQ0[(BmtDNA$B$r$b$C$F$$$F$b!"L5>I>u$J$b$N$+$i!"HsFC0[E*>I>u!J6ZNODc2I>u$r<($9$b$N$^$G$HI}$,$"$j$^$9!#IBM}3XE*$K7l4I!J>.F0L.!K$N0[>o$,$"$k!J7l4IJ?3j6Z$K0[>o%_%H%3%s%I%j%"$,A}2C$7$F$$$k!K$3$H$+$i!"7l4I7O$N0[>o$,K\>I$NH/>I$KBg$-$/4XM?$7$F$$$k$H9M$($i$l$F$$$^$9!#(B
$B!!@.?MH/>I$b$"$j$^$9$,!"B?$/$O>.;y4|$K:G=i$NG>B4Cf$K;w$?>I>u$,=P8=$7$^$9!#45B4CfMM>I>u$,=P8=$9$kA0$+$i!"Dc?HD9!"0WHhO+!"7ZEY$N6ZNODc2<$r$_$k$3$H$,B?$$$H$5$l$F$$$^$9!#G>B4CfMM>I>u$OSREG$rH<$&H/:n@-$NF,DK!"a[Z;!"0U<1>c32$G!"2sI|8e$KJRKcac!";kNO>c32!JB?$/$O0l2a@-!K$r;D$7$^$9!#G>B4CfMM>I>u$O?t;~4V$+$i?tF|B3$-!"$=$N4V$O9bF};@7l>I$K$h$kBeB4Cf$H0[$J$j!"Kcac$N$h$&$J>I>u$O0l2a@-$GDL>o$OB.$d$+$K2wI|$7$^$9!#(B
$B!!H/:n>I>u$r7+$jJV$9$K$D$l!"CNE*B`9T!"$F$s$+$s!"H>LU!J;~$KN>B&@-!K!"6ZNODc2<$,?J9T$7!"$k$$$=$&!"46@w!"?UITA4$J$I$G$r$_$k$3$H$b$"$j$^$9!#(B
$B!!7l@6$H$/$K?q1U$NF};@CM$,@5>o$N#2G\0J>e$H9b$/$J$j$^$9!#G>(BCT/MRI$B$G$OB?Ac@-$NG>9<:IN`;w$N=j8+$r8eF,ItM%0L$KG'$a$^$9!J?^#3#2!K!#(B
$B?^#3#2(B:$B%a%i%9$NG>(BMRI(T1$B6/D42hA|(B) $B8eF,It!J/$J$/G>9<:I$N8e$N=j8+$K;w$k!#%a%i%9$G$O$3$N$h$&$K!"8eF,MU$KIBJQ$,6/$$798~$,$"$k!#(B

$BIB5$$,?J9T$9$k$H(I$$BK\>I$N$h$&$KG><<$N3HBg!"G>$N0`=L$,L\N)$D$h$&$K$J$k!#(B
$B?^#3#2(B:$B%a%i%9$NG>(BMRI(T1$B6/D42hA|(B)
$B!!$?$@$7!"Xm45It0L$OI,$:$7$bBg!&Cf7l4I$N;YG[NN0h$H$O0lCW$7$J$$$H$3$m$,!"@.?M$NG>9<:I$H0[$J$k$H$3$m$G$9!#6Z@88!$G$O@V?'$\$m@~0]$H$H$b$K!"Ls#8#0!s$K7l4I7O$N0[>o!J%3%O%/;@C&?eAG9ZAG@w?'$GG;@w$9$k7l4I!'(Bstrongly succinate dehydorgenase (SDH)-reactive blood vessels: SSV)$B!J?^#3#3!K$r$_$^$9!#%_%H%3%s%I%j%"(BDNA$BJQ0[$O7l1U$+$iJ,N%$7$?#D#N#A$G8!::$,$G$-$^$9!#(B
$B?^#3#3(B:$B6ZAH?%Fb$N0[>o7l4I(B(SSV) $B%_%H%3%s%I%j%"$r$h$/@w$a$k%3%O%/;@C&?eAG9ZAG(B(succinate dehydrogenase: SDH)

$B@w?'$9$k$H!"@5>o6Z!J:8(B:N$B!K$G$O7l4I$O$[$H$s$I@w$^$i$J$$!#(B

$B%a%i%9!J1&(B:MELAS$B!K$G$O7l4IJI$,6/$/@w$^$j!"0[>o$J%_%H%3%s%I%j%"$,7l4IJI$KC_@Q$7$F$$$k$3$H$,J,$+$k!#(B
$B?^#3#3(B:$B6ZAH?%Fb$N0[>o7l4I(B(SSV)
$B!!<#NE$K$O:,K\E*$J$b$N$O$"$j$^$;$s!#H/:n;~$K$OM"1U$K$h$k%"%7%I!<%7%9$NJd@5!"%9%F%m%$%IEjM?!";@AG5[F~$r9T$$$^$9!#%+%k%8%*%/%m!<%`$N@ECm$,M-8z$G$"$k$H$NJs9p$,$"$j$^$9!#$^$?%8%/%m%m?];@$H$$$&2=3XJ*I$KM-8z$H$5$l$F$$$^$9!#(B

$B!y(B$B%^!<%U(B$B!J(Bmyoclonus epilepsy associated with ragged-red fibers$B!'(BMERRF$B$O?@7P3XMQ8l=8$G$O@V?'$\$m@~0]!&%_%*%/%m!<%L%9$F$s$+$s>I8u72$HLu$5$l$F$$$k$,%^!<%U$H8F$V$N$,0lHLE*$G$"$k!#$"$k$$$OJ!86IB$H$b$h$P$l$k!K(B
$B!!%^!<%U$O%_%*%/%m!<%L%9!"A4?H@-$N$F$s$+$sH/:n!">.G>@-<:D4$rI>u$H$7Jl7O0dEA$r$H$j$^$9!#Ls#9#0!s$N45ZL@$G$-$^$9!#(BMELAS$B$G$_$i$l$?$h$&$K!"Jl$dF1K&$OL5>I>u$+$iE57?Nc$^$G$HI}$,$"$j$^$9!#(B
$B!!H/>I$O>.;y4|$+$i@.?M$^$G$HI}9-$$$G$9!#B?$/$O%_%*%/%m!<%L%9!J6ZFy$,%T%/%T%/$HF0$/8=>]$G$9!K!">.G><:D4$G5$IU$+$l$^$9!#$1$$$l$sH/:n$OA4?H@-$N6/D>!"4VBe@-$G$9!#B?$/$OH/>IA0$+$i0WHhO+@-$,8+$i$l$^$9!#7P2a$H$H$b$Ka[Z;!"6ZNODc2I$r9gJ;$7$^$9!#(B
$B!!8!::$G$O7l1U!"FC$K?q1U$NF};@CM$N>e>:$,$_$i$l$^$9!#6Z@88!$G$O@V?'$\$m@~0]!"%A%H%/%m!<%`#c;@2=9ZAGItJ,7gB;!"#S#S#V$J$I$,#8#0!s0J>e$N45 $B!!<#NE$OBP>IE*$G!"%a%i%9$HF1$8$G$9!#%P%k%W%m;@$O%_%H%3%s%I%j%"$N%+%k%K%A%sBe
$B!y(B$B%j!(B$B>I!J(BLeigh encephalomyelopathy)
$B!!K\>I$OG>4pDl3K!"G>44It$K:81&BP>N@-$N2u;`@-IBJQ$r$_$k?@7PIBM}3XE*?GCGL>!JIBM}2rK6$r$7$F!"$O$8$a$F860x$,J,$+$k?GCGL>!K$G$7$?!#$7$+$7!"2hA|?GCG$N?JJb$K$h$j!"IBJQIt0L$,3NG'$G$-$k$h$&$K$J$C$F!"NW>2?GCGL>$H$J$C$F$$$^$9!#(B
$BE57?Nc$OF};y4|$KH/>I$7$^$9!#H/0iH/C#$NDd;_!"6ZNO!&6Z6[D%Dc2c32!"CNE*B`9T$rI>u$H$7$^$9!#?J9TNc$G$O6Z6[D%$,P6?J$9$k$3$H$b$"$j$^$9!#8F5[ITA4!"$k$$$=$&$GH/>I8e?tG/$G;`$NE>5"$r$H$k$3$H$b$"$j$^$9$,!"Cf$K$O<#NE$K$h$j2~A1$9$k?M$b$$$^$9!#7l@6!"?q1U$NF};@CM$O>e>:$7$^$9!#G>(BCT/MRI$B$GG>4pDl3K$dG>44!JG>$NCf?4It$K$"$j$^$9!K$N0[>o$,?GCGE*$G$9!J?^#3#4!K!#(B
$BG>$N4pDl3K!J@~>rBN!K$K(B
$B:81&BP>N@-$N2u;`IBJQ!J"*!K(B
$B$,$_$($k!#(B
$B?^#3#4!'%j!<G>>I$NG>#C#TA|(B
$B?^#3#4!'%j!>I$NG>#C#TA|(B
$B!!K\>I$N860x$O0l$D$G$O$"$j$^$;$s!#%_%H%3%s%I%j%"(BDNA$B$N(BATPase$B%3!<%INN0h$KJQ0[$r;}$D45o@w?'BNNt@-0dEA$r$H$k$H9M$($i$l$F$$$^$9!#%j!>I$NLs(B20$B!s$N45l9g$O%_%H%3%s%I%j%"(BDNA$B$G$J$/!"3K(BDNA$B$,%3!<%I$9$k(BSURF1$B$H$$$&0dEA;R$KJQ0[$,$"$j$^$9!#%_%H%3%s%I%j%"IB$G3K$N0dEA;R$KJQ0[$,$_$D$+$C$?DA$7$$Nc$G$9!#860x$,J,$+$C$?$b$N$K%T%k%S%s;@C&?eAG9ZAGJ#9gBN(B(pyruvate dehydrogenase complex: PDHC)$B7gB;$,$"$j$^$9$,!"$3$l$O%j!>I$N?t!s$r@j$a$k$@$1$G$9!#$G$9$+$i!"%j!>I$NH>?t0J>e$O860x$H$J$k0[>o$,8+$$$@$5$l$F$$$J$$$3$H$K$J$j$^$9!#(B
$B!!<#NEK!$H$7$F$OFCJL$J$b$N$O$"$j$^$;$s!#$?$@!"Cf$K$O%S%?%_%s#B(B1$B$,Cx8z$9$kNc$,$"$k!J#B(B1$B0MB8@-(BPDHC$B7gB;$J$I!K$N$G!"%S%?%_%s$NEjM?$r9T$$$^$9!#$^$?%"%7%I!<%7%9!J7l1U$N;@@-EY$,6/$/$J$k!K$K$O%8%/%m%m?];@$,8z2L$"$j$^$9!#(B

$B!y(B$B%A%H%/%m!<%`#c;@2=9ZAG7gB;(B$B!J(Bcytochrome c oxidase: COX deficiency)$B!!(B
$B!!%_%H%3%s%I%j%"IB$K$O9ZAG7gB;$,$_$$$@$5$l!"@82=3XE*$JJ,N`$G$N?GCGL>$,$"$j$^$9!#$=$NCf$G:G$bB?$$$N$,%A%H%/%m!<%`#c;@2=9ZAG!J#C#O#X!K!JJ#9gBN(BIV$B!K7gB;$G$9!#$3$N9ZAG7gB;$G%j!>I$K$b$J$j$^$9!#%j!>I0J30$N<@45$H$7$F $BF};y=E>I7?!J(Bfatal infantile form)
$B!!F};y4|$+$i6ZNO!&6Z6[D%Dc2c32!"6/$$%"%7%I!<%7%9$rH<$$#1:P0J2<$G;`K4$9$k=E>I7?$G$9!#LsH>?t$KE|G"!"CAGrG"!"HF%"%_%N;@G"(B(DeToni-Fanconi-Debre$B>I8u72!K$r$H$b$J$$$^$9!#(B
$BF};yNI@-7?(B(benign infantile form)
$B!!$-$o$a$F$^$l$G$^$@F|K\$G$O!"#1#0Nc0J2<$NJs9p$7$+$"$j$^$;$s!#>I>u$OF};y4|$K6ZNO!&6Z6[D%Dc2I>u$O2~A1$7!"B?$/$OA4$/@5>o$H$J$j$^$9!#0lIt$O40A4$K$O2sI|$7$^$;$s!#Cf?u?@7P>c32$O$"$j$^$;$s!#(B
$B>e5-$$$:$l$N<@45$b>o@w?'BNNt@-0dEA$H9M$($i$l$F$$$^$9!#6Z@88!$G$O@V?'$\$m@~0]$r$_$H$a!"#C#O#X3h@-$OAH?%2=3XE*$K$b@82=3XE*$K$bDc2<$J$$$77gB;$7$F$$$^$9!#$?$@F};yNI@-7?$G$O9ZAG$N3h@-$Oe>:$7$F$$$-$^$9!#(B

$B!y(B$B%a%s%.!<(B$B!J(Bmitochondrial neurogastrointestinal encephalomyopathy: MNGIE)$B!!(B
$B!!>o@w?'BNNt@-EA7A<0$r$H$k$^$l$J<@45$G$9!#DL>o#1#0Be$+$i#2#0Be$K<@45$K5$$E$+$l$^$9!#:G$bL\N)$D>I>u$O!"CxL@$JA4?H$N$d$;$H>C2=4o>I>u!J>C2=4I1?F0ITA4$d2$K!"4cb[2??@7P>c32$K$h$ko$N=j8+$,8+$i$l$^$9!#9|3J6Z$N%_%H%3%s%I%j%"(BDNA$B$rD4$Y$k$H!"%_%H%3%s%I%j%"(BDNA$B$N7gK3!JNL$N8:>/!K$dB?=E7g<:$H8F$P$l$kJQ0[$,8!=P$G$-$^$9!#(B
$B$3$N<@45$O!"%A%_%8%s!&%[%9%U%)%j%i!<%<$H$$$&9ZAG$N7gB;$G5/$3$j$^$9!#%A%_%8%s!&%[%9%U%)%j%i!<%<$O!"(BDNA$B$N86NA$G$"$k%A%_%8%s$rJ,2r$9$k9ZAG$G$9$,!"$3$N9ZAG$,$J$$$?$a$K!"45o$N#6#0G\DxEY$K$^$GA}2C$7$F$$$^$9!#$3$N9bG;EY$N%A%_%8%s$,!"@5>o$J%_%H%3%s%I%j%"(BDNA$B$N9g@.$rK8$2$F$$$k$N$@$H9M$($i$l$F$$$^$9!#(B
$B7l1UCf$N%A%_%8%sG;EY$H%A%_%8%s!&%[%9%U%)%j%i!<%<3h@-$rB,Dj$9$k$3$H$G!"?GCG$rIU$1$k$3$H$,=PMh$^$9!#%A%_%8%s!&%[%9%U%)%j%i!<%<0dEA;R$NJQ0[$r8+$$$@$;$P!"$5$i$K3N



$B#1#4!%(B$B%_%*%0%m%S%sG">I(B$B!J(Bmyoglobinuria)
$B!!%_%*%0%m%S%s$O%X%b%0%m%S%s$K;w$?%X%`CAGr$G!"6Z:YK&Fb$G$N;@AG1?HB$NLr3d$r2L$?$7$^$9!#6Z:YK&$NM;2r!J2u;`!K$G!"$3$NCAGr$,7lCf$KM7N%$7!"G"$+$iBgNL$KGS=P$5$l$k>uBV$r%_%*%0%m%S%sG">I$H$$$$$^$9!#?U>c32$r9gJ;$9$k$3$H$,LdBj$H$J$j$^$9!#(B
$B!!860x$O$$$m$$$m$"$j$^$9!#E|86IB$N$H$3$m$G=R$Y$??b0fIB!"(BMcArdle$BIB$J$I$N$h$&$K9ZAG7gB;$,L@$i$+$J$b$N$b$"$j$^$9!#$^$?G.I$NB?$/$O$$$m$$$m8!::$7$F$b860x$,$o$+$i$:!"FCH/@-%_%*%0%m%S%sG">I$H$7$FJ,N`$5$l$F$$$^$9!#(B

$B!y(B$B%+%k%K%A%s%Q%k%_%A!<%k%H%i%s%9%U%'%i!<%<7gB;(B$B!J(Bcarnitine palmityl transferase (CPT) deficiency)
$B!!D9:?;iKC;@$O%+%k%K%A%s$H7k9g$7$F!"%"%7%k%+%k%K%A%s$H$J$j!"%_%H%3%s%I%j%"FbKl$rDL2a$7$^$9!#%"%7%k%+%k%K%A%s$NDL2a$r=u$1$k9ZAG$,#C#P#T$G$9!##C#P#T!](BI, II$B$,$"$j!"9ZAG7gB;$O(BI$B$NJ}$,05E]E*$KB?$$$H$5$l$F$$$^$9!#(B
$B!!D9;~4V$N1?F0!"522n!JE|J,$NJd5kITB-!K$,M60x$H$J$C$F!"6ZNODc2 $B!!7l@6%/%l%"%A%s%-%J!<%o$G$9!#AK7l2<1?F0Ii2Y;n83$G$OF};@CM!"%"%s%b%K%"$O@5>o$HF1$8$h$&$K>e>:$7$^$9!#Dc;iKC!"8eE|
$B!y(B">$B%[%9%[%0%j%;%m%`%?!<%$B!J(Bphosphoglyceromutase (PGM), phosphoglycerate kinase (PGK), lactic dehydrogenase M$B!J#L#D#H(B-$B#M(B) subunit deficiencies)
$B!!#P#G#M7gB;$O>.;y4|$+$i$N1?F0;~$NM-DK@-$N6Za[Z;$rI>u$H$7$^$9!#$^$@?tNc$NJs9p$,$"$k$N$_$G!"$-$o$a$F$^$l$G$9!#(B
$B!!#P#G#K7gB;$O#XO":?Nt@-0dEA$r$H$j!"F};y4|$+$iMO7l@-IO7l!"Cf?u?@7P7O0[>o$r$_$^$9!#$?$@$7!"7l1U0[>o$KK3$7$/!"6Za[Z;$H7+$jJV$9%_%*%0%m%S%sG"$N$_$r$_$k6Z7?$b$"$j$^$9!#AK7l2<1?F0Ii2Y;n83$G$OF};@$N>e>:$O$_$i$l$^$;$s!#(B
$B!!#L#D#H!]#M7gB;$O$o$,9q$G:G=i$KJs9p$5$l$?<@45$G$9!#1?F0;~$N6ZDK!"6Za[Z;$rI>u$H$7$^$9!#AK7l2<1?F0Ii2Y;n83$G$OF};@CM$N>e>:$O>/$J$$$,%T%k%S%s;@CM$O>e>:$9$k$H$$$o$l$F$$$^$9!#(B

$B!y(B
$B0-@-9bG.(B$B!J(Bmalignant hyperthermia)
$B!!A4?HKc?l2<$G6Z$,9ED>$7!"9bG.$r;}B3!";~$K?4Dd;_$rMh$9<@45$G$9!#Kc?lLt$N%O%m%;%s!"6ZCP4K:^$N%5%/%7%s$,.K&BN$,2aIR$H$J$j!">.K&BN$+$iBgNL$N%+%k%7%&%`$,6Z:YK&Fb$KJ|=P$5$l!"6Z9ED>$,;}B3!"6Z:YK&$O2u;`$K4Y$j$^$9!#(B
$B!!M%@-0dEA$r$H$k$b$N$,$"$j!"$=$l$O%j%"%N%8%s$N6Z<@45$b!"0lHL?M$h$j$OKc?l;~$K0-@-9bG.$rMh$7$d$9$$$HJs9p$5$l$F$$$^$9!#6Z<@45$N$"$k45
$B!y(B$B0-@->I8u72(B$B!J(Bmalignant syndrome)
$B!!8~@:?@Lt$rI~MQ$N45!"H/G.$J$I0-@-9bG.MM$N>I>u$r$_$k$3$H$,$"$j$^$9!#860x$O0-@-9bG.$H0[$J$j!"Cf?u?@7P7O$N0[>o$K$h$k$H9M$($i$l$F$$$^$9!#(B




$B#1#5!%(B$B1s0L7?%_%*%Q%A!<(B$B!J(Bdistal myopathies$B!K(B
$B!!6Z%8%9%H%m%U%#!<$O6m44$d;M;h$N6a0L6Z$,9%$s$G?/$5$l$^$9!#$7$+$76Z%8%9%H%m%U%#!<$NCf$K$O;M;h$N1s0L$,9%$s$G?/$5$l$kIB7?$,CN$i$l$F$$$^$9!#$=$l$O1s0L7?%_%*%Q%A!<$"$k$$$O1s0L7?6Z%8%9%H%m%U%#!<$H$h$P$l$F$$$^$9!#(B

$B!y(B$B;09%7?1s0L7?6Z%8%9%H%m%U%#!<(B$B!J(Bautosomal recessive distal muscular dystrophy; Miyoshi myopathy$B!K(B
$B!!K\7?$OFAEgBg3X$N;09%OBIWL>M@65o@w?'BNNt@-0dEA$r$H$j0dEA;R:B$OBh#2@w?'BNC1OS(B(2p13)$B$K$"$j!"$=$N0dEA;R;:J*$O%8%9%U%'%k%j%s(B(dysferlin)$B$HL>IU$1$i$l$^$7$?!#$3$NCAGr$O:YK&Kl$K6I:_$9$k$3$H$OLH1VAH?%3XE*@w?'$G>ZL@$5$l$F$$$^$9!#?GCG$N%9%/%j!<%K%s%0$KLrN)$D!#$3$N%8%9%U%'%k%j%s0dEA;RJQ0[$HCAGr$N7gB;$O;hBS7?6Z%8%9%H%m%U%#!INc$NCf$G!"$3$N%8%9%U%'%k%j%s$,$I$l$/$i$$$NIQEY$G7gB;$7$F$$$k$N$+$O$^$@ITL@$G$9!#:G6a(BSJL$B%^%&%9$H$$$&FMA3JQ0[I$N%b%G%kF0J*$H$7$FCmL\$r=8$a$F$$$^$9!#(B
$BNW>2>I>u$O#2#0!]#3#0Bf$K2o$G5$IU$+$l$^$9!J?^#3#5!K!#?J9T$OB.$$$b$N$G$OH/>I8e#1#0G/0L$GI>u$K:9$,$"$k$H$$$o$l$F$$$^$9!#$3$NIB5$$G$O?4B!$d8F5[4o$O?/$5$l$K$/$$$N$G@8L?E*M=8e$O$h$$$H$5$l$F$$$^$9!#(B
$B?^(B35-1$B?^(B35-2 $BF,It!">e;h$K$O$[$H$s$I0[>o$,$_$i$l$J$$!#(B
$BK\>I$G$O!"$U$/$i$O$.$N6ZFy$,FC$K6/$/?/$5$l$k$?$a!"2
$B?^#3#5!';09%7?1s0L7?6Z%8%9%H%m%U%#!<(B
$B6Z%8%9%H%m%U%#!<$G$9$N$G7l@6%/%l%"%A%s%-%J!<%e>:$7$^$9!#6Z(BCT/MRI$B$G$O2
$B?^#3#6!';09%7?1s0L7?6Z%8%9%H%m%U%#!<$N6Z#C#TA|(B $B$U$/$i$O$.$NCf1{It$N2#CGA|!#(B
$BB-$N8eLL$N%R%i%a6Z!J!z!K!"g$J"6Z!J!z!z!K$,(B
$BFC$K6/$/?/$5$l$F$$$k!#(B
$B?^#3#6!';09%7?1s0L7?6Z%8%9%H%m%U%#!<$N6Z#C#TA|(B

$B!y(B$B1o$B!J(Bdistal myopathy with rimmed vacuoles; Nonaka myopathy$B!K(B
$B!!>o@w?'BNNt@-0dEA$r$H$j!"0dEA;R:B$OBh#9@w?'BN$K$"$j!"(BUDP-N-$B%"%;%A%k%0%k%3%5%_%s#2!]%(%T%a%i!<%<(B/N-$B%"%;%A%k%^%s%N%5%_%s%-%J!<%
$B!!6Z@88!$r$9$k$H!"6Z@~0]$NCf$K:Y$+$$pyN3>u$NJ*
$B?^#3#7!'1o<h$j6uK&!J(Brimmed vacuole$B!K(B $B@88!6Z$K%4%b%j%H%j%/%m!<%`JQK!@w?'$r$9$k$H!"@V?'$N:Y$+$$pyN3>u$N=8$^$j$d!"$=$l$,1o
$B?^#3#7!'1o

$B!!1oC2=$7$^$9!J$3$l$r<+8JlE?)$H$$$$$^$9!K!#$=$N>l=j$,1o'$5$l$F$$$^$9!#(B
$B!!>I>u$O#2#0!]#3#0:PBf$K8=$l$k$3$H$,BgH>$G$9!#2I>u$,$_$i$l$^$9!J?^#3#8!K!#$9$0$K2
$B2 $B$,0`=L$9$k$N$,FCD'E*$G$"$k!#(B
$B?^#3#8!'1o<h$j6uK&7?1s0L7?%_%*%Q%A!<(B
$B?^#3#8!'1o
$B6Z@~0]$N2u;`$O>/$J$$$N$G!"7l@6%/%l%"%A%s%-%J!<%e>:DxEY$G$9!#?GCG$K$O6Z@88!$,I,MW$G$9!#6Z$N?/$5$lJ}$KFCD'!J2 $B:#$N$H$3$m!"<#NEK!$O$J$/!"IB5$$N?J9T$r>/$7$G$bM^$($k%j%O%S%j%F!<%7%g%s$,Bg@Z$G$9!#(B

$B!y4c0vF,1s0L7?%_%*%Q%A!<(B(oculopharyngodistal myopathy)

$BF|K\$NN$5H1IFsO:@h@8$,:G=i$KJs9p$5$l$^$7$?!#4c0vF,7?6Z%8%9%H%m%U%#!

$B!!(B$B>o@w?'BNM%@-0dEA$G$9$N$G!"2HB2$NCf$KF1$8$h$&$J>I>u$NJ}$,$$$^$9!#$3$N4c0vF,1s0L7?%_%*%Q%A!<$H4c0vF,7?6Z%8%9%H%m%U%#!<$,F1$8IB5$$+$I$&$+D9$/O@Ah$,B3$$$F$$$^$7$?!#:G6a$o$?$7$?$A$,0dEA;R$rD4$Y$?$H$3$m!"B?$/$N?M$O4c0vF,7?6Z%8%9%H%m%U%#!<$N0dEA;RJQ0[!J(BPABPN1$B!K$r$b$C$F$$$^$;$s$G$7$?!#$G$bCf$K$O$b$C$F$$$k?M$b$$$^$7$?!#$9$J$o$AB?$/$N?M$O4c0vF,7?6Z%8%9%H%m%U%#!<$H$O0[$J$k860x$GIB5$$,5/$3$C$F$$$^$9!#(B

$B!!(B$B@8L?E*M=8e$O$h$/E7e=Q$r!"$b$N$,0{$_9~$_$K$/$$?M$K$b



$B#1#6!%(B$B6Z6/D>@-%8%9%H%m%U%#!<(B(myotonic dystrophy)
$B!!6Z6/D>!J%_%*%H%K!<8=>](B:myotonia$B!K$H$O6ZFy$,0lEY<}=L$7$?8e$KCP4K$7$K$/$$!J$b$H$N@E;_>uBV$K$J$k$N$K;~4V$,$+$+$k!K$3$H$r8@$$$^$9!#$?$H$($P45(B: grip myotonia$B!K!J?^#3#9!K!#?G;!;~$KJl;X5e6Z$rBGg'4o!J?G;!MQ%O%s%^!$7!"$9$0$K$O$^$C$9$0$K$J$i$J$$$N$G$9!J(Bpercussion myotonia$B!K!#$3$N$h$&$J6Z6/D>$rI>u$H$9$k<@45$K$O$$$/$D$+$N@-%8%9%H%m%U%#!<$G$9!#(B
$B?^#3#9!'6Z6/D>!!0.$k(B $B?^#3#9!'6Z6/D>!!3+$/(B
$B?^#3#9!'6Z6/D>(B
$B $B;X!JFC$KJl;X!K$,$9$0$K85$KLa$i$J$$!J1&!K!#(B

$B#a(B.$BIB0x!&IBBV!&IBM}(B
$B!!K\>I$O>o@w?'BNM%@-0dEA$r$H$j!"Bh#1#9@w?'BND9OS(B(19q13)$B$K0dEA;R:B$,$"$j$^$9!#0dEA;R$O%/%m!<%K%s%0$5$l$F$$$F!"$=$N0dEA;R;:J*$O?7$7$/8+$D$+$C$?9ZAG$G%_%*%H%K%s%-%J!<%<(B(myotonin kinase)$B!JCAGr$rNU;@2=$73h@-2=$5$;$k9ZAG!K$HL?L>$5$l$^$7$?!#$3$N9ZAG$,IB5$$NH/>I$K$I$N$h$&$K4XM?$7$F$$$k$+$O$^$@$h$/J,$+$C$F$$$^$;$s!#(B
$B!!45o$J?M$G$O$3$N(BCTG$B$N7+$jJV$7G[Ns$O#5!]#3#02s$G$9$,!"45o@w?'BNM%@-0dEA$NIB5$$G$9!#$3$N7+$jJV$7$N?t$HNW>2>I>u$OAj4X$9$k$H$$$o$l$F$$$^$9!#$^$??F$h$j;R$I$b!";R$I$b$h$jB9$X$H@$Be$r7P$k$K=>$C$F$3$N7+$jJV$7$N?t$,A}2C$7!">I>u$O=E$/$J$k798~$K$"$j$^$9!#$3$N$3$H$rI=8=B%?J(B(anticipation)$B$H$$$$$^$9!#(B
$B!!6ZFy$r82Hy6@$G$_$k$H6Z%8%9%H%m%U%#!<$N$h$&$J2u;`$H$=$l$KB3$/:F@8=j8+$O$[$H$s$I$"$j$^$;$s!#6Z@~0]$O:Y$/$J$j!"FC$K%?%$%W#1!J@V6Z!K@~0]$,0`=L$7$^$9!#(B

b.$BNW>2>I>u(B
$B!!6Z6/D>8=>]$O6ZNODc2<$K@hN)$C$F$_$i$l$k$3$H$,B?$$$H$$$o$l$F$$$^$9!#I>u$G$9!#6Z6/D>8=>]$OF10lF0:n$r7+$jJV$9$H $B!!6ZNODc2<$,$"$-$i$+$K$J$kG/Np$O0lDj$7$F$$$^$;$s$,!"IaDL;R$I$b$G$O$"$^$jL\N)$A$^$;$s!#4iLL6Z$O9bIQEY$K?/$5$l!"I=>p$KK3$7$/!"KK$,$3$1$?$h$&$J4i$K$J$j$^$9!J6Z@-4iKF(B:myopathic face)$B!#$H$-$K>e$^$V$?$,2<$,$j!J4cb[2 $B!!6ZFy$N>I>u0J30$K$b$$$m$$$m$J>I>u$r9gJ;$7$^$9!#A0F,ItM%0L$NC&LS$,@.?MCK@-$N#8#0!s!"GrFb>c$O9bIQEY$K$_$i$l$^$9$N$G!"Dj4|E*$J4c2J$N?G;!$,I,MW$G$9!#FbJ,Hg7O$N0[>o!J%$%s%]%F%s%9!"L57n7P!"ITG%$J$I!K!"?46Z>I!"JXHk$J$I$N>C2=4o$N0[>o$r$_$k$3$H$b$"$j$^$9!#(B

c.$B?GCG(B
$B!!45

[$BIm(B]$B!!@hE7@-6Z6/D>@-%8%9%H%m%U%#!<(B(congenital myotonic dystrophy)
$B!!@hE7@-6Z6/D>@-%8%9%H%m%U%#!<$O6Z6/D>@-%8%9%H%m%U%#!<$NJl?F!J$4$/$^$l$KIc?F!K$+$i@8$^$l$?;R$I$b$K!"?7@8;~4|$+$i=E$$6ZFy$HCf?u?@7P>I>u$r$_$kIB5$$G$9!#0dEA;R2r@O$G$O!"(BCTG$B$N7+$jJV$7$N?t$OJl?F$h$j!";R6!$NJ}$,05E]E*$KB?$/$J$C$F$$$^$9!#(B
$B!!?7@8;~4|$+$i6/$$6ZNO$H6Z6[D%Dc2<$r$_$H$a$^$9!#=E>INc$G$O8F5[$N<+N)$,$J$/!"?M9)8F5[4o$,I,MW$G$9!#$^$?1m2<>c32$,$"$k$H!"7P4I1IM\$,I,MW$H$J$j$^$9!#6ZNODc2<$OA4?H@-$G4i$N6ZNO$bp$KK3$7$/!"8}$r>o$KH>J,3+$1$F$$$^$9!#F};y4|$K;`K4$9$k$h$&$J=E>INc$b$"$j$^$9$,!"@.D9$H$H$b$Kc32$rH<$$$^$9!#(B
$B!!?GCG$O$^$:Jl?F$N6Z6/D>$r3NG'$9$k$3$H$G$9!#0dEA;R2r@O$G?GCG$r3NDj$9$k$3$H$,$G$-$^$9!#(B



$B!!(B$B6Z6/D>@-%8%9%H%m%U%#!<$K$D$$$F$O!"0e3X=q1!$+$i!V6Z6/D>@-%8%9%H%m%U%#!<$N<#NE$H%1%"!W@UG$JT=8!'@n0f=<(B$B!"#3!$#3#0#01_$,=PHG$5$l$F$$$^$9!J")#1#1#3!]#8#7#1#9!!El5~ETJ85~6hK\6?#5!]#2#4!]#3!!0e3X=q1!!!EEOC#0#3!]#3#8#1#7!]#5#6#0#0!K!#$3$NIB5$$N;v$,A4$F>\$7$/5-:\$5$l$F$$$^$9$N$G$4;2>H$/$@$5$$!#(B

$B$^$?!"?GCG$H<#NE$B6Z6/D>@-%8%9%H%m%U%#!$B!W(B
$B%T!<%?!


$B#1#7!%(B
$B%@%N%sIB(B$B!J(BDanon disease$B!K(B
$B!!(BX$BO":?M%@-0dEA(B$B$N$^$l$J<@45$G!"A4@$3&$G?t==Nc$NJs9p$,$"$k$K$9$.$^$;$s!#HnBg7??46Z>I$H%_%*%Q%A!<$,I>u$G$9!#7Z$$CNE*H/C#CYBZ$rH<$&Nc$b$"$j$^$9!#?46Z>I$O!"$7$P$7$PIT@0L.$rH<$$!"FMA3;`$rMh$9$3$H$,$"$k$?$aCm0U$,I,MW$G$9!#%_%*%Q%A!<$O7ZEY$J$3$H$b$"$j$^$9$,!"$=$N$h$&$JNc$G$b7l@6%/%l%"%A%s%-%J!<%e>:$7$F$$$^$9!#6ZAH?%$r8+$k$H!"6Z@~0]Fb$KB??t$N>.6uK&$,8+$i$l$^$9!#EE;R82Hy6@$G8+$k$H!"$3$l$i$N6uK&$OB??t$N6Z@~0]Jx2u;:J*$r4^$s$G$*$j!"<+8JlE?)6uK&$"$k$$$O<+?)6uK&$H8F$P$l$^$9!#(B
$B$3$N<@45$O!"%j%=%=!<%`$NKl$K$"$k(BLAMP-2$B!J(Blysosome-associated membrane-2$B!(%i%s%W!&%D!C2=$7$^$9!#=>$C$F!"%@%N%sIB$G$O!"<+8JlE?)6uK&$H%j%=%=!<%`$H$NAj8_:nMQ$K2?$i$+$NLdBj$,$"$j!"6uK&FbIt$NJ*C2=$G$-$J$$$N$@$m$&$H9M$($i$l$F$$$^$9!#(B
$B!ZA0$X![(B $B!c!]!](B $B!ZL\ $B!]!]!d(B $B!Z $B!D!D!D(B $B!Z%"%$%&%(%*=gL\